Eisai Alzheimer’s Drug Gets FDA Decision Date; Advisory Meeting Is Planned
The FDA has accepted Eisai’s application seeking full approval for its Alzheimer’s disease drug, setting a summer date for a regulatory decision that could smooth the path for insurance companies to begin coverage for…
Continue Reading